Krista Davis is CHRO & VP at ANI PHARMACEUTICALS INC (ANIP). They have made 3 open-market trades across 1 company since 2023, most recently 2026-03-09.
CIK 0001946439
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 51,946 | $3.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL · 10b5-1 | 2026-03-06 | 2026-03-10 | $74.33 | $488K | -1.8% | +5.4% | +5.4% |
| ANIP | SELL | 2026-02-19 | 2026-02-23 | $77.74 | $296K | +0.3% | -1.7% | +7.8% |
| ANIP | SELL · 10b5-1 | 2025-12-18 | 2025-12-19 | $82.40 | $267K | -4.8% | +4.1% | -9.2% |
| ANIP | SELL · 10b5-1 | 2025-09-19 | 2025-09-22 | $98.04 | $98K | -7.2% | -2.4% | -16.0% |
| ANIP | SELL | 2025-08-22 | 2025-08-25 | $91.10 | $321K | +5.6% | +5.2% | -10.3% |
| ANIP | SELL · 10b5-1 | 2025-03-19 | 2025-03-20 | $65.00 | $121K | +7.2% | +7.2% | +1.9% |
| ANIP | SELL · 10b5-1 | 2025-03-07 | 2025-03-10 | $60.86 | $61K | +9.4% | +12.2% | +7.4% |
| ANIP | SELL · 10b5-1 | 2025-02-21 | 2025-02-24 | $60.20 | $60K | +9.0% | +19.9% | +4.1% |
| ANIP | SELL · 10b5-1 | 2024-12-11 | 2024-12-12 | $60.00 | $60K | -3.7% | -4.1% | +12.5% |
| ANIP | SELL | 2023-11-15 | 2023-11-16 | $53.81 | $282K | -4.2% | +2.0% | +9.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.